New Vaccines Offer Hope for Long Covid Sufferers
Over 65 million people worldwide suffer from long Covid, with symptoms that can persist for months or even years. New vaccines based on mRNA technology, developed by Moderna and Pfizer-BioNTech, provide updated protection against the latest subvariants of the omicron strain. These vaccines reduce the chances of getting Covid-19 and long Covid, and can help mitigate the impact of both. With Covid-19, flu, and RSV rates expected to spike during the winter months, experts emphasize the importance of getting vaccinated. The development of mRNA vaccines, which won the Nobel Prize in Physiology or Medicine, has been a game-changer in the fight against the pandemic.